Gunilla Enblad

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Ma, Jing; Sarén, Tina; Jin, Chuan; Kim, Hyeong Su et al.

Part of Cancer Immunology and Immunotherapy, 2025

• DOI for Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
• Download full text (pdf) of Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Development of myeloid neoplasia associated with prolonged immune cell-associated hematotoxicity after CAR T-cell treatment of B-cell lymphoma: Should we surveille for pre-existing myeloid mutations?

Carlsten, Mattias; Lindfors Rossi, Elisa Linnea; Jaedersten, Martin; Tesi, Bianca et al.

Part of HemaSphere, 2025

• DOI for Development of myeloid neoplasia associated with prolonged immune cell-associated hematotoxicity after CAR T-cell treatment of B-cell lymphoma: Should we surveille for pre-existing myeloid mutations?
• Download full text (pdf) of Development of myeloid neoplasia associated with prolonged immune cell-associated hematotoxicity after CAR T-cell treatment of B-cell lymphoma: Should we surveille for pre-existing myeloid mutations?

Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden

Jerkeman, Mats; Mellgren, Karin; Sonnevi, Kristina; Lisak, Mikael et al.

Part of Leukemia, p. 1256-1259, 2025

• DOI for Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden
• Download full text (pdf) of Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden

Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13

Euler, Nora; Hellbacher, Erik; af Klint, Erik; Hansson, Monika et al.

Part of Clinical Immunology, 2025

• DOI for Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13
• Download full text (pdf) of Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13

Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors

Tarai, Sambit; Lundström, Elin; Sjöholm, Therese; Jönsson, Hanna et al.

Part of Heliyon, 2024

• DOI for Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors
• Download full text (pdf) of Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Ma, Jing; Sarén, Tina; Jin, Chuan; Kim, Hyeong Su et al.

Part of Cancer Immunology and Immunotherapy, 2025

• DOI for Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
• Download full text (pdf) of Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Development of myeloid neoplasia associated with prolonged immune cell-associated hematotoxicity after CAR T-cell treatment of B-cell lymphoma: Should we surveille for pre-existing myeloid mutations?

Carlsten, Mattias; Lindfors Rossi, Elisa Linnea; Jaedersten, Martin; Tesi, Bianca et al.

Part of HemaSphere, 2025

• DOI for Development of myeloid neoplasia associated with prolonged immune cell-associated hematotoxicity after CAR T-cell treatment of B-cell lymphoma: Should we surveille for pre-existing myeloid mutations?
• Download full text (pdf) of Development of myeloid neoplasia associated with prolonged immune cell-associated hematotoxicity after CAR T-cell treatment of B-cell lymphoma: Should we surveille for pre-existing myeloid mutations?

Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden

Jerkeman, Mats; Mellgren, Karin; Sonnevi, Kristina; Lisak, Mikael et al.

Part of Leukemia, p. 1256-1259, 2025

• DOI for Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden
• Download full text (pdf) of Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden

Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13

Euler, Nora; Hellbacher, Erik; af Klint, Erik; Hansson, Monika et al.

Part of Clinical Immunology, 2025

• DOI for Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13
• Download full text (pdf) of Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13

Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors

Tarai, Sambit; Lundström, Elin; Sjöholm, Therese; Jönsson, Hanna et al.

Part of Heliyon, 2024

• DOI for Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors
• Download full text (pdf) of Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors

Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer

Sköld, Camilla; Corvigno, Sara; Dahlstrand, Hanna; Enblad, Gunilla et al.

Part of Cancer Causes and Control, p. 1101-1109, 2024

• DOI for Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer
• Download full text (pdf) of Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

De Laere, Bram; Crippa, Alessio; Discacciati, Andrea; Larsson, Berit et al.

Part of Nature Medicine, 2024

• DOI for Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
• Download full text (pdf) of Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

The National Swedish Lymphoma Register - a systematic validation of data quality

Smedby, Karin E.; Eloranta, Sandra; Wasterlid, Tove; Falini, Victor et al.

Part of Acta Oncologica, p. 563-572, 2024

• DOI for The National Swedish Lymphoma Register - a systematic validation of data quality
• Download full text (pdf) of The National Swedish Lymphoma Register - a systematic validation of data quality

Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers

Forsgren, Elin; Ekberg, Sara; Smedby, Karin E.; Nylund, Patrick et al.

Part of British Journal of Haematology, p. 1794-1803, 2024

• DOI for Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers
• Download full text (pdf) of Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers

Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study

Wästerlid, Tove; Dietrich, Caroline E.; Oksanen, Anna; Deleskog Spångberg, Linn et al.

Part of eJHaem, p. 516-526, 2024

• DOI for Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study
• Download full text (pdf) of Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study

Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis

Ren, Weicheng; Wan, Hui; Abd Own, Sulaf; Berglund, Mattias et al.

Part of Leukemia, p. 438-441, 2024

• DOI for Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
• Download full text (pdf) of Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis

Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy

Harrysson, Sara; Eloranta, Sandra; Ekberg, Sara; Enblad, Gunilla et al.

Part of Leukemia and Lymphoma, p. 534-537, 2024

• DOI for Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy

Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

Luminari, Stefano; Fossa, Alexander; Trotman, Judith; Molin, Daniel et al.

Part of Journal of Clinical Oncology, p. 13-18, 2024

• DOI for Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial
• Download full text (pdf) of Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

A whole-body diffusion MRI normal atlas: development, evaluation and initial use

Sjöholm, Therese; Tarai, Sambit; Malmberg, Filip; Strand, Robin et al.

Part of Cancer Imaging, 2023

• DOI for A whole-body diffusion MRI normal atlas: development, evaluation and initial use
• Download full text (pdf) of A whole-body diffusion MRI normal atlas: development, evaluation and initial use

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

Apollonio, Benedetta; Spada, Filomena; Petrov, Nedyalko; Cozzetto, Domenico et al.

Part of Journal of Clinical Investigation, 2023

• DOI for Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma
• Download full text (pdf) of Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients

Sarén, Tina; Ramachandran, Mohanraj; Gammelgård, Gustav; Lövgren, Tanja et al.

Part of Clinical Cancer Research, p. 4139-4152, 2023

• DOI for Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients
• Download full text (pdf) of Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients

Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2

Ginman, Beatrice; Pahnke, Simon; Freyhult, Eva; Hoffman, Tove et al.

Part of Acta Oncologica, p. 1707-1715, 2023

• DOI for Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2
• Download full text (pdf) of Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

Nikkarinen, Anna; Lokhande, Lavanya; Amini, Rose-Marie; Jerkeman, Mats et al.

Part of Blood Advances, p. 5304-5313, 2023

• DOI for Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

ADAR1-mediated RNA editing promotes B cell lymphomagenesis

Pecori, Riccardo; Ren, Weicheng; Pirmoradian, Mohammad; Binder, Marco et al.

Part of iScience, 2023

• DOI for ADAR1-mediated RNA editing promotes B cell lymphomagenesis
• Download full text (pdf) of ADAR1-mediated RNA editing promotes B cell lymphomagenesis

Next generation pan-cancer blood proteome profiling using proximity extension assay

Alvez, Maria Bueno; Edfors, Fredrik; von Feilitzen, Kalle; Zwahlen, Martin et al.

Part of Nature Communications, 2023

• DOI for Next generation pan-cancer blood proteome profiling using proximity extension assay
• Download full text (pdf) of Next generation pan-cancer blood proteome profiling using proximity extension assay

Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma-Possible Estrogen Effects

Huang, Dan; Berglund, Mattias; Damdimopoulos, Anastasios; Antonson, Per et al.

Part of Cancers, 2023

• DOI for Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma-Possible Estrogen Effects
• Download full text (pdf) of Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma-Possible Estrogen Effects

Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

Weibull, Caroline E.; Wasterlid, Tove; Wahlin, Bjorn Engelbrekt; Andersson, Per-Ola et al.

Part of HemaSphere, 2023

• DOI for Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden
• Download full text (pdf) of Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis

Hellström, Vivan; Tufveson, Gunnar; Loskog, Angelica; Bengtsson, Mats et al.

Part of PLOS ONE, 2022

• DOI for Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis
• Download full text (pdf) of Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis

Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology

Skaftason, Aron; Qu, Ying; Abdulla, Maysaa; Nordlund, Jessica et al.

Part of Genes, Chromosomes and Cancer, p. 27-36, 2022

• DOI for Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
• Download full text (pdf) of Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology

Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Abdulla, Maysaa; Hollander, Peter; Lindskog, Cecilia; Sundström, Christer et al.

Part of Acta Oncologica, p. 824-829, 2022

• DOI for Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Elsawy, Mahmoud; Chavez, Julio C.; Avivi, Irit; Larouche, Jean-Francois et al.

Part of Blood, p. 2248-2260, 2022

• DOI for Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes

Sköld, Camilla; Koliadi, Anthoula; Enblad, Gunilla; Stålberg, Karin et al.

Part of International Journal of Cancer, p. 773-781, 2022

• DOI for Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes
• Download full text (pdf) of Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes

Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Sabaa, Amal Abu; Shen, Qiujin; Lennmyr, Emma; Enblad, Anna Pia et al.

Part of New Biotechnology, p. 21-29, 2022

• DOI for Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
• Download full text (pdf) of Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt et al.

Part of Journal of Clinical Oncology, p. 1487-1496, 2022

• DOI for Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
• Download full text (pdf) of Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Sjöholm, Therese; Korenyushkin, Alexander; Gammelgård, Gustav; Sarén, Tina et al.

Part of Cancer Imaging, 2022

• DOI for Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
• Download full text (pdf) of Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Bratulic, Sinisa; Limeta, Angelo; Dabestani, Saeed; Birgisson, Helgi et al.

Part of Proceedings of the National Academy of Sciences of the United States of America, 2022

• DOI for Noninvasive detection of any-stage cancer using free glycosaminoglycans
• Download full text (pdf) of Noninvasive detection of any-stage cancer using free glycosaminoglycans

The dual role of CD70 in B‐cell lymphomagenesis

Nie, Man; Ren, Weicheng; Ye, Xiaofei; Berglund, Mattias et al.

Part of Clinical and Translational Medicine, 2022

• DOI for The dual role of CD70 in B‐cell lymphomagenesis
• Download full text (pdf) of The dual role of CD70 in B‐cell lymphomagenesis

COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients

Sundberg, Emil; Hoffman, Tove; Nilsson, Anna; Pahnke, Simon et al.

Part of Pediatric Blood & Cancer, 2022

• DOI for COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients
• Download full text (pdf) of COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients

Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients

Harrysson, Sara; Eloranta, Sandra; Ekberg, Sara; Enblad, Gunilla et al.

Part of British Journal of Haematology, p. 267-277, 2022

• DOI for Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
• Download full text (pdf) of Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients

Checkpoint CD47 expression in classical Hodgkin lymphoma

Gholiha, Alex Reza; Hollander, Peter; Löf, Liza; Glimelius, Ingrid et al.

Part of British Journal of Haematology, p. 580-589, 2022

• DOI for Checkpoint CD47 expression in classical Hodgkin lymphoma
• Download full text (pdf) of Checkpoint CD47 expression in classical Hodgkin lymphoma

Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Gholiha, Alex R.; Hollander, Peter; Löf, Liza; Larsson, Anders et al.

Part of Cancers, 2022

• DOI for Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue
• Download full text (pdf) of Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?

Andersson, Anne; Enblad, Gunilla; Erlanson, Martin; Johansson, Ann-Sofie et al.

Part of Upsala Journal of Medical Sciences, 2021

• DOI for High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
• Download full text (pdf) of High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?

Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

Kinch, Amelie; Baecklund, Eva; Molin, Daniel; Pauksen, Karlis et al.

Part of Acta Oncologica, p. 771-778, 2021

• DOI for Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
• Download full text (pdf) of Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Abdulla, Maysaa; Alexsson, Andrei; Sundström, Christer; Ladenvall, Claes et al.

Part of Acta Oncologica, p. 531-538, 2021

• DOI for PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
• Download full text (pdf) of PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma

Vajavaara, Heli; Ekeblad, Frida; Holte, Harald; Jorgensen, Judit et al.

Part of Haematologica, p. 2502-2506, 2021

• DOI for Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
• Download full text (pdf) of Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma

Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study

Ullgren, Helena; Camuto, Angela; Rosas, Sumy; Pahnke, Simon et al.

Part of Acta Oncologica, p. 1459-1465, 2021

• DOI for Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study
• Download full text (pdf) of Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Gholiha, Alex R.; Hollander, Peter; Glimelius, Ingrid; Hedström, Gustaf et al.

Part of Blood Advances, p. 1671-1681, 2021

• DOI for Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

Harrysson, Sara; Eloranta, Sandra; Ekberg, Sara; Enblad, Gunilla et al.

Part of Blood Cancer Journal, 2021

• DOI for Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
• Download full text (pdf) of Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study

Sabaa, Amal Abu; Mörth, Charlott; Hasselblom, Sverker; Hedström, Gustaf et al.

Part of British Journal of Haematology, p. 906-914, 2021

• DOI for Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study
• Download full text (pdf) of Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study

Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Sima, Andreea; Hollander, Peter; Baecklund, Eva; Smedby, Karin E. et al.

Part of British Journal of Haematology, p. 568-579, 2021

• DOI for Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden
• Download full text (pdf) of Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma

Mattsson Ulfstedt, Johan; Venge, Per; Holmgren, Sofia; Enblad, Gunilla et al.

Part of Upsala Journal of Medical Sciences, 2021

• DOI for Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
• Download full text (pdf) of Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma

Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy

Wenthe, Jessica; Naseri, Sedigheh; Labani-Motlagh, Alireza; Enblad, Gunilla et al.

Part of Cancer Immunology and Immunotherapy, p. 2851-2865, 2021

• DOI for Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
• Download full text (pdf) of Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy

Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Mörth, Charlott; Sabaa, Amal Abu; Freyhult, Eva; Christersson, Christina et al.

Part of Cardio-Oncology, 2021

• DOI for Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
• Download full text (pdf) of Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Crippa, Alessio; De Laere, Bram; Discacciati, Andrea; Larsson, Berit et al.

Part of Trials, 2020

• DOI for The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
• Download full text (pdf) of The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival

Persson Skare, Tor; Sjöberg, Elin; Berglund, Mattias; Smith, Ross O. et al.

Part of eJHaem, p. 199-207, 2020

• DOI for Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival
• Download full text (pdf) of Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

Niinivirta, Marjut; Georganaki, Maria; Enblad, Gunilla; Lindskog, Cecilia et al.

Part of BMC Cancer, 2020

• DOI for Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
• Download full text (pdf) of Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Lagerlöf, Ingemar; Holte, Harald; Glimelius, Ingrid; Björkholm, Magnus et al.

Part of British Journal of Haematology, p. 685-691, 2020

• DOI for No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

CD30 expression and survival in posttransplant lymphoproliferative disorders

Kinch, Amelie; Amini, Rose-Marie; Hollander, Peter; Molin, Daniel et al.

Part of Acta Oncologica, p. 673-680, 2020

• DOI for CD30 expression and survival in posttransplant lymphoproliferative disorders
• Download full text (pdf) of CD30 expression and survival in posttransplant lymphoproliferative disorders

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Amini, Rose-Marie; Ljungström, Viktor; Abdulla, Maysaa; Cavelier, Lucia et al.

Part of American Journal of Hematology, 2020

• DOI for Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
• Download full text (pdf) of Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study

Benoni, Henrik; Eloranta, Sandra; Dahle, Dag O.; Svensson, My H. S. et al.

Part of Transplant International, p. 1700-1710, 2020

• DOI for Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study
• Download full text (pdf) of Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study

Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Hollander, Peter; Ginman, Beatrice; Molin, Daniel; Enblad, Gunilla et al.

Part of Immunobiology, 2020

• DOI for Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma
• Download full text (pdf) of Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Abdulla, Maysaa; Guglielmo, Priscilla; Hollander, Peter; Åström, Gunnar et al.

Part of European Journal of Haematology, p. 207-213, 2020

• DOI for Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma
• Download full text (pdf) of Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma

Wästerlid, Tove; Harrysson, Sara; Andersson, Therese M-L; Ekberg, Sara et al.

Part of American Journal of Hematology, p. 740-748, 2020

• DOI for Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
• Download full text (pdf) of Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma

Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Hellbacher, Erik; Hjorton, Karin; Backlin, Carin; Enblad, Gunilla et al.

Part of Acta Oncologica, p. 1655-1659, 2019

• DOI for Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Gholiha, Alex R.; Hollander, Peter; Hedström, Gustaf; Sundström, Christer et al.

Part of British Journal of Haematology, p. 192-201, 2019

• DOI for High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Amini, Rose-Marie; Enblad, Gunilla; Hollander, Peter; Laszlo, S. et al.

Part of BMC Cancer, 2019

• DOI for Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
• Download full text (pdf) of Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib

Niinivirta, Marjut; Enblad, Gunilla; Lindskog, Cecilia; Pontén, Fredrik et al.

Part of Journal of Cancer, p. 3224-3231, 2019

• DOI for Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
• Download full text (pdf) of Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib

Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy

Pedersen, Mette A.; Gormsen, Lars C.; Kamper, Peter; Wassberg, Cecilia et al.

Part of British Journal of Haematology, p. 431-439, 2019

• DOI for Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy

Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome

Mörth, Charlott; Valachis, Antonios; Sabaa, Amal Abu; Marshall, Katharina et al.

Part of Acta Oncologica, p. 1170-1177, 2019

• DOI for Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Kinch, Amelie; Sundström, Christer; Baecklund, Eva; Backlin, Carin et al.

Part of Leukemia and Lymphoma, p. 376-384, 2019

• DOI for Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
• Download full text (pdf) of Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius, Bengt; Melin, Beatrice; Enblad, Gunilla; Alafuzoff, Irina et al.

Part of Acta Oncologica, p. 187-194, 2018

• DOI for U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
• Download full text (pdf) of U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

Hollander, Peter; Amini, Rose-Marie; Ginman, Beatrice; Molin, Daniel et al.

Part of PLOS ONE, 2018

• DOI for Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
• Download full text (pdf) of Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?

Mörth, Charlott; Valachis, Antonis; Sabaa, Amal Abu; Molin, Daniel et al.

Part of Annals of Hematology, p. 2129-2135, 2018

• DOI for Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
• Download full text (pdf) of Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

Hollander, Peter; Rostgaard, Klaus; Ekström-Smedby, Karin; Molin, Daniel et al.

Part of European Journal of Haematology, p. 88-97, 2018

• DOI for An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome
• Download full text (pdf) of An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Enblad, Gunilla; Karlsson, Hannah; Gammelgård, Gustav; Wenthe, Jessica et al.

Part of Clinical Cancer Research, p. 6185-6194, 2018

• DOI for A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

Harrysson, Sara; Eloranta, Sandra; Ekberg, Sara; Enblad, Gunilla et al.

Part of Blood, 2018

• DOI for Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Smedby, Karin Ekstrom; Harrysson, Sara; Andersson, Per-Ola; Enblad, Gunilla et al.

Part of Blood, 2018

• DOI for Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Imiomics Using Whole-body FDG PET/MR in Staging and Treatment Response Evaluation of Non-Hodgkin Lymphoma Patients Treated With CAR-T Cells

Guglielmo, P.; Sjöholm, Therese; Enblad, Gunilla; Strand, Robin et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients

Ednersson, Susanne Bram; Stenson, Martin; Stern, Mimmie; Enblad, Gunilla et al.

Part of British Journal of Haematology, p. 770-781, 2018

• DOI for Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients

Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study

Wasterlid, T.; Biccler, J. L.; Brown, P. N.; Bogsted, M. et al.

Part of Annals of Oncology, p. 1882-1883, 2018

• DOI for Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma

Ekberg, Sara; Jerkeman, Mats; Andersson, Per-Ola; Enblad, Gunilla et al.

Part of American Journal of Hematology, p. 1020-1028, 2018

• DOI for Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma

Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013

Eloranta, Sandra; Brånvall, Elsa; Celsing, Fredrik; Papworth, Karin et al.

Part of European Journal of Haematology, p. 61-68, 2018

• DOI for Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

Niinivirta, Marjut; Enblad, Gunilla; Edqvist, Per-Henrik D; Pontén, Fredrik et al.

Part of Journal of Cancer, p. 3975-3983, 2017

• DOI for Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
• Download full text (pdf) of Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research

Abdulla, Maysaa; Laszlo, Sofia; Triumf, Johanna; Hedström, Gustaf et al.

Part of Acta Oncologica, p. 106-109, 2017

• DOI for Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research

High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Hollander, Peter; Kamper, Peter; Smedby, Karin Ekstrom; Enblad, Gunilla et al.

Part of Blood Advances, p. 1427-1439, 2017

• DOI for High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

Enblad, Gunilla; Martinsson, Gustaf; Baecklund, Eva; Hesselager, Göran et al.

Part of Acta Oncologica, p. 599-607, 2017

• DOI for Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib

Niinivirta, Marjut; Enblad, Gunilla; Edqvist, Per-Henrik; Pontén, Fredrik et al.

Part of Journal of Cancer Research and Clinical Oncology, p. 961-970, 2017

• DOI for Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
• Download full text (pdf) of Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib

Estrogen receptor beta 1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

Hasni, Muhammad Sharif; Berglund, Mattias; Yakimchuk, Konstantin; Guan, Jiyu et al.

Part of Leukemia and Lymphoma, p. 418-427, 2017

• DOI for Estrogen receptor beta 1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

Immunological biomarkers correlate to survival in CAR19-treated patients

Lövgren, Tanja; Wenthe, Jessica; Karlsson, S. C. Hannah; Gammelgård, Gustav et al.

Part of Scandinavian Journal of Immunology, p. 337-337, 2017

Does the omission of vincristine affect outcome and survival in patients with diffuse large B-cell lymphoma?

Mörth, Charlott; Valachis, Antonis; Abu Sabaa, Amal; Hedström, Gustaf et al.

Part of Annals of Oncology, 2017

Risk Factors for De Novo Squamous Cell Carcinoma Development in Renal Transplant Recipients with a Previous Squamous Cell Carcinoma.

Hellström, Vivan; Enström, Ylva; Enblad, Gunilla; Tufveson, Gunnar et al.

Part of Acta Dermato-Venereologica, p. 751-753, 2017

• DOI for Risk Factors for De Novo Squamous Cell Carcinoma Development in Renal Transplant Recipients with a Previous Squamous Cell Carcinoma.

Donor Derived and BK Virus Positive Urologic Cancers After Renal Transplantation

Hellström, Vivan; Tufveson, Gunnar; Wallgren, AnnaCarin; Loskog, Angelica et al.

Part of American Journal of Transplantation, p. 472-472, 2017

• DOI for Donor Derived and BK Virus Positive Urologic Cancers After Renal Transplantation

Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma

Delforoush, Maryam; Berglund, Mattias; Edqvist, Per-Henrik; Sundström, Christer et al.

Part of European Journal of Haematology, p. 52-56, 2017

• DOI for Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma

High posttransplant cancer incidence in renal transplanted patients with pretransplant cancer

Hellström, Vivan; Lorant, Tomas; Döhler, Bernd; Tufveson, Gunnar et al.

Part of Transplantation, p. 1295-1302, 2017

• DOI for High posttransplant cancer incidence in renal transplanted patients with pretransplant cancer

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

Mansouri, Larry; Noerenberg, Daniel; Young, Emma; Mylonas, Elena et al.

Part of Blood, p. 2666-2670, 2016

• DOI for Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

In vitro and in vivo activity of melflufen (J1) in lymphoma

Delforoush, Maryam; Strese, Sara; Wickström, Malin; Larsson, Rolf et al.

Part of BMC Cancer, 2016

• DOI for In vitro and in vivo activity of melflufen (J1) in lymphoma

Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing

Quentmeier, Hilmar; Drexler, Hans G.; Hauer, Vivien; MacLeod, Roderick A. F. et al.

Part of PLOS ONE, 2016

• DOI for Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing
• Download full text (pdf) of Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing

Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study

Melén, Christopher M.; Enblad, Gunilla; Sonnevi, Kristina; Junlen, Henna Riikka et al.

Part of British Journal of Haematology, p. 614-622, 2016

• DOI for Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study

A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients

Abdulla, Maysaa; Laszlo, Sofia; Triumf, Johanna; Hedström, Gustaf et al.

Part of Acta Oncologica, p. 1126-1131, 2016

• DOI for A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

Georgiou, Konstantinos; Chen, Longyun; Berglund, Mattias; Ren, Weicheng et al.

Part of Blood, p. 3026-3034, 2016

• DOI for Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children

Englund, Annika; Molin, Daniel; Enblad, Gunilla; Karlén, Jonas et al.

Part of European Journal of Haematology, p. 430-438, 2016

• DOI for The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children
• Download full text (pdf) of The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children

Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study

Hellström, Vivan; Enström, Ylva; von Zur-Mühlen, Bengt; Hagberg, Hans et al.

Part of Acta Oncologica, p. 774-781, 2016

• DOI for Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study

CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial

Enblad, Gunilla; Karlsson, Hannah; Wikström, Kristina I.; Essand, Magnus et al.

Part of CANCER IMMUNOLOGY RESEARCH, 2016

• DOI for CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma

Johnson, Peter; Federico, Massimo; Kirkwood, Amy; Fossa, Alexander et al.

Part of New England Journal of Medicine, p. 2419-2429, 2016

• DOI for Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma

A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Enblad, Gunilla; Karlsson, Hannah; Wenthe, Jessica; Wikström, Kristina I. et al.

Part of Molecular Therapy, 2016

High Expression Of Programmed Cell Death Receptor 1 In The Tumor Microenvironment Is Associated With Inferior Event Free Survival In Classical Hodgkin Lymphoma

Hollander, Peter; Kamper, P.; Smedby, K. E.; Enblad, Gunilla et al.

Part of Haematologica, p. 1-2, 2016

The Importance Of Bone Marrow 18F-Fdg Uptake And Focal Skeletal Lesions On Survival In Patients With Newly Diagnosed Hodgkin Lymphoma

Pedersen, M. A.; Gormsen, L. C.; Kamper, P.; d'Amore, A. et al.

Part of Haematologica, p. 42-42, 2016

Prognostic Implications Of An Active, Innate Or Anergic Immune Response In The Hodgkin Lymphoma Tumor Microenvironment

Hollander, Peter; Rostgaard, K.; Smedby, K. E.; Molin, Daniel et al.

Part of Haematologica, p. 3-3, 2016

Impact of age in an unselected population of Diffuse large B-cell lymphomas: a population-based study

Hedström, Gustaf; Hagberg, Oskar; Jerkeman, Mats; Enblad, Gunilla

Part of Acta Oncologica, p. 916-923, 2015

• DOI for Impact of age in an unselected population of Diffuse large B-cell lymphomas: a population-based study

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia

Mansouri, Larry; Sutton, Lesley-Ann; Ljungström, Viktor; Bondza, Sina et al.

Part of Journal of Experimental Medicine, p. 833-843, 2015

• DOI for Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
• Download full text (pdf) of Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia

Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells

Strömberg, Thomas; Feng, Xiaoying; Delforoush, Maryam; Berglund, Mattias et al.

Part of Medical Oncology, 2015

• DOI for Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells

Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Berglund, David; Kinch, Amelie; Edman, Elin; Backlin, Carin et al.

Part of Transplantation, p. 1036-1042, 2015

• DOI for Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Hodgkin lymphoma - a survey of children and adolescents treated in Sweden 1985-2009.

Englund, Annika; Hopstadius, Charlotte; Enblad, Gunilla; Gustafsson, Göran et al.

Part of Acta Oncologica, p. 41-8, 2015

• DOI for Hodgkin lymphoma - a survey of children and adolescents treated in Sweden 1985-2009.

The impact of age on survival of diffuse large B-cell lymphoma - a population-based study

Hedström, Gustaf; Hagberg, Oskar; Jerkeman, Mats; Enblad, Gunilla

Part of Acta Oncologica, p. 916-923, 2015

• DOI for The impact of age on survival of diffuse large B-cell lymphoma - a population-based study

Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study

Hedström, Gustaf; Peterson, Stefan; Berglund, Mattias; Jerkeman, Mats et al.

Part of Acta Oncologica, p. 924-932, 2015

• DOI for Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study

Elevated Post-Transplant Cancer Incidence And Reduced Survival In Patients With Pretransplant Tumors

Hellström, Vivan; Lorant, Tomas; Dohler, Bernd; Tufveson, Gunnar et al.

Part of Transplant International, p. 183-184, 2015

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Enblad, Gunilla; Karlsson, Hannah; Wikström, Kristina; Essand, Magnus et al.

Part of Blood, 2015

Recurrent Mutations within the Nfkbie gene: A Novel Mechanism for NF-kappa B Deregulation in Aggressive Chronic Lymphocytic Leukemia

Mansouri, Larry; Sutton, Lesley-Ann; Ljungström, Viktor; Bondza, Sina et al.

Part of Blood, 2014

Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

Kinch, Amelie; Cavelier, Lucia; Bengtsson, Mats; Baecklund, Eva et al.

Part of American Journal of Transplantation, p. 2838-2845, 2014

• DOI for Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade

Libard, Sylwia; Popova, Svetlana N; Amini, Rose-Marie; Kärjä, Vesa et al.

Part of PLOS ONE, 2014

• DOI for Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade
• Download full text (pdf) of Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade

Ro52/TRIM21 Expression is Decreased in Malignant B Cells

Ivanchenko, Margarita; Brauner, Susanna; Enblad, Gunilla; Sundström, Christer et al.

Part of Scandinavian Journal of Immunology, p. 453-454, 2014

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Kinch, Amelie; Baecklund, Eva; Backlin, Carin; Ekman, Tor et al.

Part of Acta Oncologica, p. 669-679, 2014

• DOI for A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma

Hedström, Gustaf; Thunberg, Ulf; Amini, Rose-Marie; Zainuddin, Norafiza et al.

Part of European Journal of Haematology, p. 500-508, 2014

• DOI for The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma

Diffusely Increased Bone Marrow 18F-FDG Uptake Is an Independent Predictor of Focal Bone Lesions in Patients with Newly Diagnosed Classical Hodgkin Lymphoma

Gormsen, Lars C.; Wassberg, Cecilia; Molin, Daniel; Kamper, Peter et al.

Part of Blood, 2014

Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients

de Miranda, Noel F. C. C.; Georgiou, Konstantinos; Chen, Longyun; Wu, Chenglin et al.

Part of Blood, p. 2544-2553, 2014

• DOI for Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients

Treatment of Metastatic Malignant Melanoma With Vemurafenib During Pregnancy

Maleka, Aglaia; Enblad, Gunilla; Sjörs, Gunnar; Lindqvist, Anna et al.

Part of Journal of Clinical Oncology, 2013

• DOI for Treatment of Metastatic Malignant Melanoma With Vemurafenib During Pregnancy

Ro52 Expression is a Prognostic Factor for Survival in B Cell Lymphoma

Brauner, Susanna; Zhou, Wei; Backlin, Carin; Green, Tina M. et al.

Part of Annals of the Rheumatic Diseases, 2013

• DOI for Ro52 Expression is a Prognostic Factor for Survival in B Cell Lymphoma

DNA repair genes are selectively mutated in diffuse large B cell lymphomas

de Miranda, Noel F. C. C.; Peng, Roujun; Georgiou, Konstantinos; Wu, Chenglin et al.

Part of Journal of Experimental Medicine, p. 1729-1742, 2013

• DOI for DNA repair genes are selectively mutated in diffuse large B cell lymphomas

High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma

Berglund, Mattias; Hedström, Gustaf; Amini, Rose-Marie; Enblad, Gunilla et al.

Part of Oncology Reports, p. 720-724, 2013

• DOI for High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma

Low expression of microRNA-129-5p predicts poor clinical outcome in diffuse large B cell lymphoma (DLBCL)

Hedström, Gustav; Thunberg, Ulf; Berglund, Mattias; Simonsson, Martin et al.

Part of International Journal of Hematology, p. 465-471, 2013

• DOI for Low expression of microRNA-129-5p predicts poor clinical outcome in diffuse large B cell lymphoma (DLBCL)

Treatment of metastatic malignant melanoma with vemurafenib during pregnancy

Maleka, Aglaia; Enblad, Gunilla; Sjörs, Gunnar; Lindqvist, Anna et al.

Part of Journal of Clinical Oncology, 2013

• DOI for Treatment of metastatic malignant melanoma with vemurafenib during pregnancy
• Download full text (pdf) of Treatment of metastatic malignant melanoma with vemurafenib during pregnancy

Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis

Du, Likun; Peng, Roujun; Björkman, Andrea; Filipe de Miranda, Noel et al.

Part of Journal of Experimental Medicine, p. 291-305, 2012

• DOI for Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis

Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup.

Thunberg, Ulf; Enblad, Gunilla; Berglund, Mattias

Part of Haematologica, 2012

• DOI for Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup.

Sex Differences in Fertility-Related Information Received by Young Adult Cancer Survivors

Armuand, Gabriela M.; Rodriguez-Wallberg, Kenny A.; Wettergren, Lena; Ahlgren, Johan et al.

Part of Journal of Clinical Oncology, p. 2147-2153, 2012

• DOI for Sex Differences in Fertility-Related Information Received by Young Adult Cancer Survivors

Molecular Studies of Mechanisms of Drug Resistance in Malignant Cells With Focus on Lymphomas

Delforoush, Maryam; Berglund, Mattias; Enblad, Gunilla

Part of European Journal of Cancer, 2012

• DOI for Molecular Studies of Mechanisms of Drug Resistance in Malignant Cells With Focus on Lymphomas

Njurtransplanterade med maligna tumörer en växande patientgrupp: [Kidney transplanted persons with malignant tumors is a growing patient group]

Hellström, Vivan; Wilczek, Henryk; Roussos, Jana; Lorant, Tomas et al.

Part of Läkartidningen, p. 1766-1769, 2012

TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia

Zainuddin, Norafiza; Murray, Fiona; Kanduri, Meena; Gunnarsson, Rebeqa et al.

Part of Leukemia Research, p. 272-274, 2011

• DOI for TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia

Quantitative evaluation of p16^INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma

Zainuddin, Norafiza; Kanduri, Meena; Berglund, Mattias; Lindell, Monica et al.

Part of Leukemia Research, p. 438-443, 2011

• DOI for Quantitative evaluation of p16^INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma

Is a TNF Alpha Polymorphism Responsible for Mutations in the TP53 Gene?

Berglund, Mattias; Zainuddin, N.; Thunberg, Ulf; Enblad, Gunilla

Part of Scandinavian Journal of Immunology, p. 154-155, 2011

• DOI for Is a TNF Alpha Polymorphism Responsible for Mutations in the TP53 Gene?

Both CD4(+) FoxP3(+) and CD4(+) FoxP3(-) T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Lindqvist, Camilla; Christiansson, Lisa; Thörn, Ingrid; Mangsbo, Sara et al.

Part of Immunology, p. 296-306, 2011

• DOI for Both CD4(+) FoxP3(+) and CD4(+) FoxP3(-) T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's Lymphoma: a population-based study

Glimelius, Ingrid; Rubin, Jenny; Rostgaard, Klaus; Amini, Rose Marie et al.

Part of European Journal of Haematology, p. 208-216, 2011

• DOI for Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's Lymphoma: a population-based study

The effect of Eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines

Glimelius, Ingrid; Rubin, Jenny; Fischer, Marie; Molin, Daniel et al.

Part of Experimental Hematology, p. 850-858, 2011

• DOI for The effect of Eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines

LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma

Baecklund, Eva; Backlin, Carin; Mansouri, Mahmoud; Klareskog, Lars et al.

Part of Leukemia and Lymphoma, p. 1146-1149, 2011

• DOI for LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma

Long term risk of infections in Hodgkin lymphoma long-term survivors

Andersson, Anne; Enblad, Gunilla; Gustavsson, Anita; Erlanson, Martin et al.

Part of British Journal of Haematology, p. 661-663, 2011

• DOI for Long term risk of infections in Hodgkin lymphoma long-term survivors

SNP rs6457327 is a predictor for overall survival in follicular lymphoma as well as survival after transformation

Berglund, Mattias; Enblad, Gunilla; Thunberg, Ulf

Part of Blood, p. 4489-4489, 2011

• DOI for SNP rs6457327 is a predictor for overall survival in follicular lymphoma as well as survival after transformation

T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies

Lindqvist, Camilla A.; Christiansson, Lisa H.; Simonsson, Bengt; Enblad, Gunilla et al.

Part of Immunology, p. 371-376, 2010

• DOI for T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies

Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients

Thunberg, Ulf; Enblad, Gunilla; Turesson, Ingela; Berglund, Mattias

Part of Leukemia and Lymphoma, p. 1563-1566, 2010

• DOI for Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients

Rheumatoid arthritis, treatment with corticosteroids, and risk of malignant lymphomas: results from a case-control study

Hellgren, Karin; Iliadou, Anastasia; Rosenquist, Richard; Feltelius, Nils et al.

Part of Annals of the Rheumatic Diseases, p. 654-659, 2010

• DOI for Rheumatoid arthritis, treatment with corticosteroids, and risk of malignant lymphomas: results from a case-control study

TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype

Zainuddin, Norafiza; Berglund, Mattias; Wanders, Alkwin; Ren, Zhi-Ping et al.

Part of Leukemia Research, p. 60-66, 2009

• DOI for TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype

Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival

Cederblad, Lena; Johansson, Silvia; Enblad, Gunilla; Engström, Mats et al.

Part of Acta Oncologica, 2009

Folate-metabolizing genes in lymphoma patients from Sweden

Berglund, Mattias; Enblad, Gunilla; Turesson, Ingela; Edman, V. et al.

Part of Scandinavian Journal of Immunology, p. 408-410, 2009

• DOI for Folate-metabolizing genes in lymphoma patients from Sweden

Cancer of the parotid gland; long-term follow-up: A single centre experience on recurrence and survival

Cederblad, Lena; Johansson, Silvia; Enblad, Gunilla; Engström, Mats et al.

Part of Acta Oncologica, p. 549-555, 2009

• DOI for Cancer of the parotid gland; long-term follow-up: A single centre experience on recurrence and survival

Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors: retrospective cohort analyses and a concept for prospective intervention

Andersson, Anne; Näslund, Ulf; Tavelin, Björn; Enblad, Gunilla et al.

Part of International Journal of Cancer, p. 1914-1917, 2009

• DOI for Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors: retrospective cohort analyses and a concept for prospective intervention

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas

Nyman, Heidi; Jerkeman, Mats; Karjalainen-Lindsberg, Marja-Liisa; Banham, Alison H. et al.

Part of European Journal of Haematology, p. 364-72, 2009

• DOI for Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas

BCL2 expression in de novo Diffuse Large B-cell Lymphoma partly reflects normal differences in age distribution

Thunberg, Ulf; Amini, Rose-Marie; Linderoth, Johan; Roos, Göran et al.

Part of British Journal of Haematology, p. 683-684, 2009

• DOI for BCL2 expression in de novo Diffuse Large B-cell Lymphoma partly reflects normal differences in age distribution

Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma

Nyman, H.; Jantunen, E.; Juvonen, E.; Elonen, E. et al.

Part of Bone Marrow Transplantation, p. 93-8, 2008

• DOI for Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma

Inflammatory cells and immune microenvironment in malignant lymphoma

de Jong, Daphne; Enblad, Gunilla

Part of Journal of Internal Medicine, p. 528-36, 2008

• DOI for Inflammatory cells and immune microenvironment in malignant lymphoma

Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma

Andersson, Anne; Enblad, Gunilla; Tavelin, B.; Björkholm, M. et al.

Part of British Journal of Cancer, p. 1001-1005, 2008

• DOI for Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

Baecklund, Eva; Natkunam, Yasodha; Backlin, Carin; Iliadou, Anastasia et al.

Part of British Journal of Haematology, p. 69-72, 2008

• DOI for Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy

Nyman, Heidi; Adde, Magdalena; Karjalainen-Lindsberg, Marja-Liisa; Taskinen, Minna et al.

Part of Blood, p. 4930-4935, 2007

• DOI for Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy

Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma

Berglund, Mattias; Thunberg, Ulf; Fridberg, Marie; Wingren, Anette Gjörloff et al.

Part of Leukemia and Lymphoma, p. 1038-1041, 2007

• DOI for Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma

Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma

Berglund, Mattias; Enblad, Gunilla; Thunberg, Ulf; Amini, Rose-Marie et al.

Part of Modern Pathology, p. 63-75, 2007

• DOI for Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma

Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

Hedström, Gustaf; Berglund, Mattias; Molin, Daniel; Fischer, Marie et al.

Part of British Journal of Haematology, p. 68-71, 2007

• DOI for Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas

Walsh, Sarah H.; Grabowski, Pawel; Berglund, Mattias; Thunberg, Ulf et al.

Part of European Journal of Haematology, p. 283-289, 2007

• DOI for Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas

The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma

Enblad, Gunilla; Molin, Daniel; Glimelius, Ingrid; Fischer, Marie et al.

Part of Hematology/Oncology Clinics of North America, p. 805-823, 2007

• DOI for The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma

Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma

Linderoth, Johan; Ehinger, Mats; Åkerman, Måns; Cavallin-Ståhl, Eva et al.

Part of European Journal of Haematology, p. 146-149, 2007

• DOI for Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma

Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN

Fridberg, Marie; Servin, Anna; Anagnostaki, Lola; Linderoth, Johan et al.

Part of Leukemia and Lymphoma, p. 2221-2232, 2007

• DOI for Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN

CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma

Linderoth, Johan; Ehinger, Mats; Jerkeman, Mats; Bendahl, Pär-Ola et al.

Part of Leukemia and Lymphoma, p. 1774-1779, 2007

• DOI for CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma

IL-9 expression contributes to the cellular composition in Hodgkin lymphoma

Glimelius, Ingrid; Edström, Annika; Amini, Rose-Marie; Fischer, Marie et al.

Part of European Journal of Haematology, p. 278-283, 2006

• DOI for IL-9 expression contributes to the cellular composition in Hodgkin lymphoma

Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion

Fischer, Marie; Harvima, Ilkka T..; Carvalho, Ricardo F. S.; Möller, Christine et al.

Part of Journal of Clinical Investigation, p. 2748-2756, 2006

• DOI for Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion

U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.

Sambade, Clara; Berglund, Mattias; Lagercrantz, Svetlana; Sällström, Jan et al.

Part of Int J Cancer, p. 555-63, 2006

Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14).

Adde, Magdalena; Enblad, Gunilla; Hagberg, Hans; Sundström, Christer et al.

Part of Med Oncol, p. 283-93, 2006

Angiogenesis and mast cells in Hodgkin lymphoma

Glimelius, Ingrid; Edström, Annika; Fischer, Marie; Nilsson, Gunnar et al.

Part of Leukemia, p. 2360-2362, 2005

• DOI for Angiogenesis and mast cells in Hodgkin lymphoma

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.

Berglund, Mattias; Thunberg, Ulf; Amini, Rose-Marie; Book, Majlis et al.

Part of Mod Pathol, p. 1113-20, 2005

The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma.

Berglund, Mattias; Thunberg, Ulf; Roos, Göran; Rosenquist, Richard et al.

Part of Blood, p. 4894-5; author reply 4895, 2005

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas.

Enblad, Gunilla; Hagberg, Hans; Erlanson, Martin; Lundin, Jeanette et al.

Part of Blood, p. 2920-4, 2004

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia.

Tobin, Gerard; Thunberg, Ulf; Karlsson, Karin; Murray, Fiona et al.

Part of Blood, p. 2879-85, 2004

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

Tobin, Gerard; Thunberg, Ulf; Johnson, Anna; Eriksson, Inger et al.

Part of Blood, p. 4952-7, 2003

Increased serum levels of Interleukin-9 correlates with negative prognostic factors in Hodgkin's lymphoma

Fischer, Marie; Molin, Daniel; Bijman, Marcel; Cormont, Francoise et al.

Part of Leukemia, p. 2513, 2003

Relationship between Hodgkin's and non-Hodgkin's lymphomas.

Amini, RM; Enblad, Gunilla

Part of Med Oncol, p. 211, 2003

Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma.

Walsh, Sarah H; Thorsélius, Mia; Johnson, Anna; Söderberg, Ola et al.

Part of Blood, p. 4047-54, 2003

Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue.

Fischer, Marie; Juremalm, Mikael; Olsson, Niclas; Backlin, Carin et al.

Part of Int J Cancer, p. 197-201, 2003

A novel B-cell line (U-2932) established from a patient with a diffuse large B-cell lymphoma following Hodgkin lymphoma

Amini, Rose-Marie; Berglund, Mattias; Rosenquist, Richard; von Heideman, Anne et al.

Part of Leukemia and Lymphoma, p. 2179-2189, 2002

• DOI for A novel B-cell line (U-2932) established from a patient with a diffuse large B-cell lymphoma following Hodgkin lymphoma

Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival

Amini, Rose-Marie; Enblad, Gunilla; Engström, Peter; Christensson, Birger et al.

Part of Leukemia and Lymphoma, p. 1253-1260, 2002

• DOI for Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival

A population-based study of the outcome for patients with first relapse of Hodgkin lymphoma

Amini, Rose-Marie; Glimelius, Bengt; Gustavsson, Anita; Ekman, Tor et al.

Part of European Journal of Haematology, p. 225-232, 2002

• DOI for A population-based study of the outcome for patients with first relapse of Hodgkin lymphoma

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

Molin, Daniel; Edström, Annika; Glimelius, Ingrid; Glimelius, Bengt et al.

Part of British Journal of Haematology, p. 122-124, 2002

• DOI for Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia

Thunberg, Ulf; Tobin, Gerard; Johnson, Anna; Söderberg, Ola et al.

Part of The Lancet, p. 1935-1939, 2002

• DOI for Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

Tobin, Gerard; Thunberg, Ulf; Johnson, Anna; Thörn, Ingrid et al.

Part of Blood, p. 2262-2264, 2002

Treatment outcome in patients younger than 60 years with advanced stages (IIB-IV) of Hodgkin's disease: the Swedish National Health Care Programme experience

Amini, Rose-Marie; Enblad, Gunilla; Gustavsson, Anita; Ekman, Tor et al.

Part of European Journal of Haematology, p. 379-389, 2000

• DOI for Treatment outcome in patients younger than 60 years with advanced stages (IIB-IV) of Hodgkin's disease: the Swedish National Health Care Programme experience

Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients

Amini, Rose-Marie; Enblad, Gunilla; Sundström, Christer; Glimelius, Bengt

Part of International Journal of Cancer, p. 510-516, 1997

• DOI for Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients

Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving EFS24 - a Swedish population-based study.

Sabaa, Amal Abu; Mörth, Charlott; Hasselblom, Sverker; Hedström, Gustaf et al.

Second cancer is the leading cause of death, with no increase of cardiovascular deaths, after combined modality Hodgkin lymphoma treatment

Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt et al.

Advances in immune therapies in hematological malignancies

Mazzarella, Luca; Enblad, Gunilla; Olweus, Johanna; Malmberg, Karl-Johan et al.

Part of Journal of Internal Medicine, p. 205-220, 2022

• DOI for Advances in immune therapies in hematological malignancies
• Download full text (pdf) of Advances in immune therapies in hematological malignancies

CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma

Enblad, Gunilla; Karlsson, Hannah; Loskog, Angelica S. I.

Part of Human Gene Therapy, p. 498-505, 2015

• DOI for CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma

Is the rs10484561 SNP responsible for differences in age at diagnosis, transformation and death of patients with follicular lymphoma?

Berglund, Mattias; Amini, Rose-Marie; Enblad, Gunilla; Thunberg, Ulf

Part of International Journal of Hematologic Oncology, p. 391-396, 2013

• DOI for Is the rs10484561 SNP responsible for differences in age at diagnosis, transformation and death of patients with follicular lymphoma?

Inhibition of the 19 S proteasome by bAP-15 in lymphoma cell lines

Delforoush, Maryam; Sun, Chao; Thomas, Strömberg; Strese, Sara et al.

PD-1 and PD-L1 are upregulated in paired consecutive biopsies with classical Hodgkin lymphoma

Hollander, Peter; Amini, Rose-Marie; Ginman, Beatrice; Enblad, Gunilla et al.

Association between parity, histopathological tumor features and survival in high-grade serous ovarian cancer

Sköld, Camilla; Tolf, Anna; Corvigno, Sara; Dahlstrand, Hanna et al.

Single-cell RNA analysis reveal subpopulations of CAR T cells correlating with response in lymphoma patients

Sarén, Tina; Ramachandran, Mohanraj; Gammelgård, Gustav; Lövgren, Tanja et al.

Preclinical evaluation of CAR20(NAP)-T cells for B cell lymphoma

Sarén, Tina; Ma, Jing; Jin, Chuan; Kim, Hyeongsu et al.

T-cell Leukaemia/Lymphoma Protein 1A (TCL1A) In Diffuse Large B-cell lymphoma (DLBCL)

Abu Sabaa, Amal; Mörth, Charlott; Berglund, Mattias; Hashemi, Jamileh et al.

Plasma Protein Profiling using Multiplex Extension Assay in Diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: A descriptive study

Abu Sabaa, Amal; Mörth, Charlott; Molin, Daniel; Freyhult, Eva et al.

Real-life data on morbidity and cause-specific mortality after combined modality treatment for Hodgkin lymphoma 2006-2015.

Lagerlöf, Ingemar; Wikman, Per; Enblad, Gunilla; Goldkuhl, Christina et al.